LYTIR

Company · TEVA

Teva Pharmaceutical Industries Limited

Name as listed on its exchange; filed with the SEC as TEVA PHARMACEUTICAL INDUSTRIES LTD.

Nasdaq's symbol directory lists TEVA on the New York Stock Exchange as “Teva Pharmaceutical Industries Limited Ordinary Shares”.

In the 12 months to Nov 8, 2026: insiders sold on 12 occasions ($24.0M); 4 planned-sale notices; 1 filing by holders of 5% or more; 1 congressional trade disclosure; 5 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $24.0M in total.Jun: Insider sales $4.0MAug: Insider sales $2.4MSep: Insider sales $14.6MNov: Insider sales $3.0MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $24.0M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Roberto Mignone sold on 1 day latest Sep 18, 2026 sold $14.4M
  2. Eliyahu Sharon Kalif, EVP, Chief Financial Officer sold on 1 day all under a 10b5-1 plan latest Jun 11, 2026 sold $3.6M
  3. Mark Sabag, See "Remarks" sold on 1 day latest Nov 5, 2026 sold $1.9M
  4. Dov Bergwerk, Interim Cheif Legal Officer sold on 1 day latest Nov 4, 2026 sold $1.1M
  5. Hughes Eric A, See "Remarks" sold on 1 day all under a 10b5-1 plan latest Aug 3, 2026 sold $892K
  6. Lippman Evan, EVP, Business Development sold on 1 day all under a 10b5-1 plan latest Aug 17, 2026 sold $680K
  7. Jover Placid, See "Remarks" sold on 1 day all under a 10b5-1 plan latest Aug 3, 2026 sold $447K
  8. Weiss Amir, Chief Accounting Officer sold on 1 day latest Aug 21, 2026 sold $355K
  9. Shields Matthew, EVP, Global Operations sold on 1 day latest Jun 18, 2026 sold $322K
  10. Savage Brian, Interim Chief Legal Officer sold on 1 day latest Sep 18, 2026 sold $285K

and 2 more people.

Every trade (12)
  1. SELLMark Sabag, See "Remarks" sold Nov 5, 2026 46,000 shares filing $1.9M
  2. SELLDov Bergwerk, Interim Cheif Legal Officer sold Nov 4, 2026 26,260 shares 2 legs combined filing $1.1M
  3. SELLRoberto Mignone sold Sep 18, 2026 367,600 shares filing $14.4M
  4. SELLSavage Brian, Interim Chief Legal Officer sold Sep 18, 2026 7,342 shares 3 legs combined filing $285K
  5. SELLWeiss Amir, Chief Accounting Officer sold Aug 21, 2026 9,445 shares 2 legs combined filing $355K
  6. SELLSatchi-Fainaro Ronit sold Aug 21, 2026 415 shares filing $15K
  7. SELLLippman Evan, EVP, Business Development sold Aug 17, 2026 18,600 shares 10b5-1 plan (scheduled) filing $680K
  8. SELLZaks Tal Zvi sold Aug 5, 2026 17 shares filing $593
  9. SELLHughes Eric A, See "Remarks" sold Aug 3, 2026 25,578 shares 10b5-1 plan (scheduled) filing $892K
  10. SELLJover Placid, See "Remarks" sold Aug 3, 2026 12,827 shares 10b5-1 plan (scheduled) filing $447K
  11. SELLShields Matthew, EVP, Global Operations sold Jun 18, 2026 9,989 shares filing $322K
  12. SELLEliyahu Sharon Kalif, EVP, Chief Financial Officer sold Jun 11, 2026 106,563 shares 10b5-1 plan (scheduled) filing $3.6M

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Sabag Mark filed Nov 5, 2026 Officer 46,000 shares planned sale date 11/05/2026 filing $1.9M
  2. Bergwerk Dov filed Nov 4, 2026 Senior VP General Counsel Corporate Secretary 26,260 shares planned sale date 11/04/2026 filing $1.1M
  3. Savage Brian filed Sep 21, 2026 Officer 7,028 shares planned sale date 09/18/2026 filing $273K
  4. Bridger Management, LLC (1) filed Sep 18, 2026 Shareholder 367,600 shares planned sale date 09/18/2026 filing $14.4M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Harel Insurance Investments & Financial Services Ltd. filed Nov 2, 2026 Schedule 13G/A passive filing 6%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Alan Armstrong (R-OK): Purchase Mar 30, 2026 reported Jul 21, 2026 one of 703 trades the member reported that day Senate Stock $1,001 - $15,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 3, 2026
  2. Departure or appointment of directors or officers filing Oct 29, 2026
  3. Entry into a material definitive agreement; Creation of a direct financial obligation filing Sep 16, 2026
  4. Other events filing Sep 14, 2026
  5. Regulation FD disclosure; Other events filing Sep 11, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.